These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 24767980)
1. High expression of Cullin1 indicates poor prognosis for NSCLC patients. Xu M; Yang X; Zhao J; Zhang J; Zhang S; Huang H; Liu Y; Liu J Pathol Res Pract; 2014 Jul; 210(7):397-401. PubMed ID: 24767980 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer. Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721 [TBL] [Abstract][Full Text] [Related]
3. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma. Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587 [TBL] [Abstract][Full Text] [Related]
4. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway. Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related]
6. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742 [TBL] [Abstract][Full Text] [Related]
7. High expression of TNFSF13 in tumor cells and fibroblasts is associated with poor prognosis in non-small cell lung cancer. Qian Z; Qingshan C; Chun J; Huijun Z; Feng L; Qiang W; Qiang X; Min Z Am J Clin Pathol; 2014 Feb; 141(2):226-33. PubMed ID: 24436270 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
9. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259 [TBL] [Abstract][Full Text] [Related]
10. High TBX2 expression predicts poor prognosis in non-small cell lung cancer. Zhang Z; Guo Y Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744 [TBL] [Abstract][Full Text] [Related]
11. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients. Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526 [TBL] [Abstract][Full Text] [Related]
13. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells. Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414 [TBL] [Abstract][Full Text] [Related]
15. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC. Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740 [TBL] [Abstract][Full Text] [Related]
16. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer. Jung CK; Jung JH; Park GS; Lee A; Kang CS; Lee KY Pathol Int; 2006 Sep; 56(9):503-9. PubMed ID: 16930330 [TBL] [Abstract][Full Text] [Related]
17. AP‑4 predicts poor prognosis in non‑small cell lung cancer. Gong H; Han S; Yao H; Zhao H; Wang Y Mol Med Rep; 2014 Jul; 10(1):336-40. PubMed ID: 24804973 [TBL] [Abstract][Full Text] [Related]
18. Significance of the correlation between the expression of interleukin 6 and clinical features in patients with non-small cell lung cancer. Koh E; Iizasa T; Yamaji H; Sekine Y; Hiroshima K; Yoshino I; Fujisawa T Int J Surg Pathol; 2012 Jun; 20(3):233-9. PubMed ID: 22334615 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer. Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323 [TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients. Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]